Hepatitis Foundation International Cultivating a community that helps people with Hepatitis concerns manage and fulfill their lives
The Good We Do Living with Hepatitis News & Research Support Education Donate Contact Us
spacer
NNAC Online Learning Center Subscribe to Our Newsletter Parents
 
 

photoWe offer living and learning resources, support and answers.

palette

Foundation for Decision Making, Liver Wellness and Prevention of Hepatitis and Drug Abuse

Learn new techniques to protect yourself, your staff and your patients. We can train your staff, healthcare providers, and educators.

Call 1-800-891-0707
for information.




Join our cause!



NNAC
 
 
National Nurses Advisory Council

Join Nurses (NNAC) Around the Nation to fill gaps in patient care and prevention initiatives!
 

United Way Donors
            2009

Your United Way donation can be made directly to HFI and UW will still get credit. Give a check made out to HFI to your captain to get credit for UW and avoid paying administrative costs.

Win Win for HFI, UW, and You
 

Federal Employees Can Choose

Hepatitis Foundation International

Make HFI -
Your Charity Of Choice

Our CFC Agency Code:

        11842

 

New CNE Course Announced


 

 

 


 

 

 

 



Coming Event


Midwest Viral Hepatitis Summit


      When: Friday, September 18, 2009
     8:30AM - 5:00PM, Columbus, OH

      Click here for more information.


Breaking News


Impact of Lifestyles on Hepatitis C


     In HCV-infected patients, the top three predictors of liver
     related mortality were having higher body mass index (BMI),
     presence of insulin resistance (IR), and elevated serum
     cholesterol. Overall mortality in HCV patients was most linked
     to metabolic syndrome, higher BMI and hypertension.
     Click here for more information.


Telaprevir Effective in Treating Previously Failured Response

    
     Vertex’s telaprevir, an experimental drug for hepatitis C, is
     showing that it can cure about half of the patients who failed to
     respond to standard treatments. The study found that 51
     percent of patients who took telaprevir in combination with
     standard drugs for six months were cured and 52 percent were
     cured.
     Click here for more information.


 Phase 3 Albureron Trials Show Promising Results

    
The Phase 3 studies conducted by Human Genome Sciences, Inc,
     known as ACHIEVE 1 and ACHIEVE 2/3, evaluated albinterferon
     alfa-2b vs. ginterferon alfa-2a, in combination with ribavirin,
     for use in the treatment of interferon-naive patients with chronic
     hepatitis C.
     Click here for more information.


Acetaminophen Painkillers to Carry Stronger Risk Warnings

      Pain relieving drugs containing Acetaminophen will be required
     to carry more explicit warning labels about the risk of liver   
     damage and stomach bleeding especially for people who
     overdose on pain medicines or who drink three or more
     alcoholic drinks each day.   
     Click here for more information.

 


 


What is HFI Doing With Your Dollars?

 

Promoting Prevention and Wellness

 

The Hepatitis Foundation International presents motivational messages that inspire and initiate individual, organizational, and societal changes that empower young and old alike to participate in their own health care and make healthful lifestyle choices.

 

Head Start Teachers Praise Messages to Help Children Stay Healthy

   
Head start teachers in Washington, DC applauded HFI's
    training to help children avoid liver damaging activities and to
    know how to take better care of their liver. Teachers
    recommended that parents also need similar support to help
    their children avoid drugs and alcohol.

Minority University Peer Educators in Illinois, Virginia and Alabama Give High Marks to HFI's Foundation For Decision Making Training


    HFI's CEO engaged college students in learning new
    information and quick-and-easy techniques to encourage their
    peers to avoid liver damaging behaviors such as binge drinking
    and activities that expose them to hepatitis, HIV, and STI's.

 

    Student's comments included: "All the information presented
    to me today will help me in training others on hepatitis
    awareness.  Not many people know about hepatitis.  Being
    able to actually tell them what cirrhosis and hepatitis are
    and even what they do will put things in perspective for
    people who don't know how bad hepatitis is and how very
    important your liver is."

 

400 Attendees at HIV OASIS Conference Learned New Prevention Messages at Plenary Session
 

    "As the executive Director of Okaloosa AIDS Support and
    Information Services I have witnessed a huge increase in
    the number of HIV and Hepatitis C confections in our clients.
    We look forward to collaborating with the Hepatitis
    Foundation International to add this important "missing link"
    in accomplishing our mutual goal of bringing HIV and hepatitis
    under control." -Butch McKay, Executive Director

 

HIV Outreach Workers Hear HFIs Liver Wellness Messages - Center for Substance Abuse Treatment Conference
 

    "The most useful info at this conference.- This will be helpful
    to my clients; videos are great.- We will contact you for
    more training for our staff." - Comments made by attendees

 

Office of Minority Health Invites HFI to Address Attendees at National Conference
 

    Asians, African Americans and other outreach workers learned
    new and effective way to encourage their constituents to
    avoid liver damaging behaviors.

 

    "The major thing I learned from this presentation is how
    important my liver is, how important it is to take care of it,
    and how to prevent putting myself and others at risk."

    -Comments made by students in post training survey

 

Attendees at SAMHSA's and CADCA's Prevention Conference Learn New Approach To Prevention of Drug Abuse, Hepatitis, HIV, and Binge Drinking
 

    Frances Harding, Director of The Center For Substance Abuse
    Prevention at SAMHSA invited HFI to conduct its Foundation
    For Decision Making Training at their Annual Prevention 
    Conference in DC.

 

    Comments by attendees included: "I am a second year
    trainee working doing a project with teenage girls on HIV &
    AIDS.  This will help me BIG TIME.  Your approach is amazing
    and totally committed to promoting liver education and
    prevention of hepatitis and HIV."


 

 

News Notes

 

Sharing Insulin Pens a NO NO

 

    Individuals may be exposed to blood-borne pathogens that
    could cause diseases like hepatitis and HIV as a result of
    sharing insulin pens and insulin cartridges, which are only
    meant for single-patient use.  Although insulin pens may
    contain enough insulin for several rounds of injection by self
    administration, the FDA has issued a health alert warning
    against the sharing of devices, as they are only approved for
    use with one patient per device.  Even if the needles are
    changed between patients, it is not safe to share the insulin
    pens or insulin cartridges.  Blood-borne pathogens, such as
    HIV and the hepatitis viruses may contaminate the reservoir
    after the injection, before the needle is changed.


 

Hep A Vaccine Recommended for Parents Adopting Children

    U.S. citizens who expect to have close contact with an an an an an an an an
    adopted child from countries with high rates of hepatitis A
    should be immunized if they have not been already, U.S.
    immunization advisers said on Wednesday.
    Click here for more information.


 

New Treatment Option for Unresectable Liver Cancer

    Nexavar is an oral multiple kinase inhibitor for the treatment of
    patients with unresectable hepatocellular carcinoma (HCC),
    the most common form of liver cancer, and patients with
    advanced renal cell carcinoma (RCC), the most common type
    of kidney cancer. Until now, patients with unresectable HCC
    have had limited treatment options.  Now, Nexavar offers a
    new treatment option with proven clinical benefits for
    unresectable HCC.  Nexavar provides the latest information
    for the treatment of patients with unresectable HCC and
    patients with advanced RCC.  It also provides links to
    comprehensive support programs to help patients with
    unresectable HCC or advanced RCC manage their therapy.



Changing Ailing Healthcare System

    Changing our ailing healthcare system includes promoting
    healthy lifestyle behaviors.  A Huge task at best.  The
    Hepatitis Foundation International (HFI) has a "leg up" on
    promoting healthy lifestyles in collaboration with many
    private and government agencies.  All Americans want to
    be healthy.
    Click here for more information.

Attention:  Men and Pregnant Women Taking Ribavirin
Registry Established for Potential Birth Defects

    The Registry enrolls pregnant women who have been
    inadvertently exposed to Ribavirin either directly (6 months
    before or during pregnancy) or indirectly (through her male
    sexual partner 6 months before or during pregnancy.

    Click here for more information


HFI’s Wellness Approach Included In CDC’s 2008 Top Five Evidence-Based Prevention Interventions.

    "Study to Reduce Intravenous Exposure" (STRIVE) was
    among the top five Evidence- Based HIV Prevention
    Interventions identified by the Centers for Disease Control
    and Prevention in 2008.
    Click here for lease.

 

CDC Study: Failures to Follow Infection Practices Placed More Than 60,000 Patients at Risk for Hepatitis B and C_

     In the last decade, more than 60,000 patients in the United
    States were asked to get tested for hepatitis B virus (HBV)
    and hepatitis C virus (HCV) because health care personnel in
    settings outside hospitals failed to follow basic infection
    control practices, according to a new study done by the CDC.
    Click here for the full press release.

 

Research Advances
Make a Donation!  We need your support!

Your online purchases can benefit HFI at no cost to you!

        
Your Opinion is
Needed To Help
Find a Cure and
Benefit HFI!


Sign up to make your voice heard.
Click Here


               ***

HFI CEO Receives Award

 

HFI's CEO Thelma King Thiel received the Above and Beyond Citizen Honors presented by the
    
Congressional Medal of Honor Foundation as an unsung hero for her extraordinary...

Click for more.


Donate to HFI

Hepatitis Foundation International (HFI) continues to work hard to provide up to date information and motivational messages for patients, educators, and the healthcare community.  We need your help to continue this important work!

Your donation to HFI can make a significant difference!





Hepatitis Foundation International
504 Blick Drive
Silver Spring, MD
20904-2901
USA
tel: 301-622-4200
800-891-0707
fax: 301-622-4702

 

     

 

the good we do  |  living with hepatitis  |  news & research  |  support donate  |  contact us  |  site map  |   home

nnac  |  online learning center  |  subscribe to our newsletter   |   disclaimer  |  privacy

 

Hepatitis Foundation International
(800) 891-0707
HFI@comcast.net

©2003. All rights reserved.

 

 
web counter